FUNCTIONS OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
FUNCTIONS OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
批准号:
6472778
负责人:
TOWIA A. LIBERMANN
金额:
$27.95万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-06 至 2003-06-30
关键词:
B lymphocyte antisense nucleic acid developmental genetics gene induction /repression genetic promoter element genetically modified animals immunogenetics laboratory mouse leukemia leukopoiesis lymphoma neoplasm /cancer genetics oligonucleotides pluripotent stem cells protein protein interaction site directed mutagenesis transcription factor
中文摘要
我们的目标是了解胚胎多能细胞如何分化
免疫系统的特定细胞类型,
导致白血病和淋巴瘤形成的发育缺陷。
我们的方法是分析转录控制机制,
发育调节β细胞特异性基因,并分离出一种新的Ets
从人脾中提取具有三种选择性剪接形式的NERF因子,
胎肝 NERF与ELF-1密切相关,Ets因子与
T细胞特异性基因表达;然而,我们的初步结果表明,
ELF-1是一种主要的β细胞核因子,
激活β细胞特异性基因中的调节元件。 NERF和
ELF-1在β细胞发育的早期高度表达,
与几个β细胞特异性基因中的Ets位点以相似的亲和力结合
亲和力最高的是β细胞酪氨酸激酶基因林恩和blk。
我们建议研究NERF的作用和作用机制
和ELF-1在使用blk基因调节β细胞特异性基因中作为
一个明显的靶基因。 我们的目的是评估NERF在以下方面的作用:
β细胞发育和分析结构/功能关系
NERF和ELF-1了解负责功能性
这两个因素之间的差异。 因此,具体目标是:
特定AIM编号1。 确定NERF和ELF-1在
β细胞特异性blk基因表达的调节。
具体目标2. 确定蛋白质-蛋白质的作用
在ELF-1或NERF的功能中的相互作用和磷酸化。
具体目标3. 确定有针对性地破坏
NERF基因对β细胞发育和blk基因表达的影响。
由于Ets家族在调节各种组织中的重要性-
和分化特异性基因,以及造血,
特别是,NERF和ELF-1预计将在Beta测试中发挥核心作用
细胞发育 说明NERF和ELF-1在细胞中的功能
调节β细胞的发育将为我们提供令人兴奋的机会,
测试这些Ets因子的功能改变导致
白血病
英文摘要
Our goal is to understand how embryonic pluripotent cells differentiate
into specific cell types of the immune system and to identify
developmental defects leading to leukemia and lymphoma formation.
Our approach is to analyze transcriptional control mechanisms for
developmentally regulated beta cell-specific gene and isolated a novel Ets
factor, NERF, with three alternative splice forms form human spleen and
fetal liver. NERF is closely related to ELF-1, and Ets factor linked to
T cell-specific gene expression; however, our preliminary results indicate
that ELF-1 is a major Beta cell nuclear factor which interacts with the
activates regulatory elements in Beta cell-specific genes. NERF and
ELF-1 are highly expressed in early stages of Beta cell development and
bind with similar affinity to Ets sites in several Beta cell-specific genes
the highest affinity is for the Beta cell tyrosine kinase genes, lyn & blk.
We propose to investigate the role and mechanism of action of NERF
and ELF-1 in regulating Beta cell-specific genes using the blk gene as
one apparent target gene. Our aim is to evaluate the role of NERF in
Beta cell development and analyze structure/function relationships of
NERF and ELF-1 to understand mechanisms responsible for functional
differences between these two factors. Thus, the specific aims are to:
Specific AIM number 1. Determine the role of NERF and ELF-1 in the
regulation of Beta cell specific blk gene expression.
Specific Aim number 2. Determine the role of protein-protein
interactions and phosphorylation in the function of ELF-1 or NERF.
Specific Aim number 3. Determine the effect of targeted disruption of
the NERF gene on Beta cell development and blk gene expression.
Due to the importance of the Ets family in regulation of various tissue-
and differentiation-specific genes, in general, and hematopoiesis, in
particular, NERF and ELF-1 are expected to play a central role in Beta
cell development. Elucidation of the function NERF and ELF-1 in
regulating Beta cell development will provide exciting opportunities to
test the hypothesis that altered functions of these Ets factor result in
leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
-
批准号:9204773
-
项目类别:
-
资助金额:$60.25万
-
财政年份:2016
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
-
批准号:9402039
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2016
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Role of Axl in docetaxel resistance in prostate cancer
-
批准号:8880713
-
项目类别:
-
资助金额:$21.11万
-
财政年份:2015
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline
-
批准号:10585942
-
项目类别:
-
资助金额:$87.41万
-
财政年份:2015
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Novel treatment strategies for enhancing sunitinib response in renal cell cancer
-
批准号:8524387
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2013
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Novel treatment strategies for enhancing sunitinib response in renal cell cancer
-
批准号:8651433
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2013
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER
-
批准号:6870870
-
项目类别:
-
资助金额:$14.62万
-
财政年份:2005
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER
-
批准号:7060081
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2005
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
CORE-- GENOMIC AND BIONFORMATICS SUPPORT
-
批准号:6946588
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2004
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6886322
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6266267
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6511364
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6633648
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6873688
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6709419
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6632335
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6321886
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6514408
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6724785
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NIDDK BIOTECHNOLOGY CENTER
-
批准号:6230920
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2000
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
海外基金